Clinical Trial Update: Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR [Phase 2, Phase 3]

View source ↗

Summary

A multi-arm Phase 2/Phase 3 study in adults with acute myeloid leukemia compares daunorubicin versus high-dose idarubicin induction, high-dose versus intermedia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Idarubicin (idarubicin)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University Hospital, Angers | Conditions: Acute Myeloid Leukemia (AML) | Phase 2, Phase 3 | Status: RECRUITING